[PDF][PDF] Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression

P Dudzik, S Trojan, B Ostrowska, M Lasota… - 2019 - frontierspartnerships.org
The CD146 (also known as MCAM, MUC-18, Mel-CAM) was initially reported on in 1987, as
a protein crucial for melanoma invasion. Recently, it has been confirmed that CD146 is …

Relationship between microRNA-9 and breast cancer

A Johannsson, L Sharma, H Mossavi… - Authorea …, 2023 - essopenarchive.org
Breast cancer is the most frequent malignancy in women and has devastating effects on
both their physical and emotional wellbeing. More cases of it are expected to surface in the …

Applications of the p53/MicroRNA-34 axis beyond cancer

J Schwartzberg - Authorea Preprints, 2023 - techrxiv.org
Human life is seriously threatened by cancer. Long years of study and data collecting have
led to a growing body of knowledge about cancer and its treatment. The p53 gene is crucial …

Review From the lab to the hospital: new ideas in miRNA medicine

H Khalil - Authorea Preprints, 2023 - techrxiv.org
Since a single miRNA may control many target genes across several pathways in a cell, it is
clear that miRNAs are very potent genetic regulators. Because of this characteristic, miRNAs …

Biomarkers for the (cancer-related) risk of thrombosis in the veins: microRNAs

M Feysal - Authorea Preprints, 2023 - techrxiv.org
Disease conditions often include dysregulation of microRNAs (miRNAs), which are short
noncoding RNAs with gene regulatory activities. MiRNAs are attractive biomarkers for the …

The role of long non-coding RNAs in the spread of breast cancer

C Doss - Authorea Preprints, 2023 - techrxiv.org
Breast cancer is the primary cause of cancer-related mortality among women. Most deaths
from breast cancer are caused by the disease coming back or spreading to other regions of …

Understanding the therapeutic potential of modulating miRNAs in the course of thyroid and breast cancer

S Davis, C Hao - Authorea Preprints, 2023 - essopenarchive.org
Thyroid cancer's frequency has skyrocketed in recent decades, making it one of the most
prevalent endocrine cancers overall. There were 586,000 instances of thyroid cancer in …

Using Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer is a Cutting-Edge Application of MicroRNA Profiling Technology

S Talbot - Authorea Preprints, 2023 - essopenarchive.org
This study presents technology to detect and quantify microRNAs (miRNAs) as possible
cancer biomarkers, using breast cancer as an example. The majority of breast cancer cases …

New therapeutic axis in blood malignancies involving microRNAs and JAK/STAT3 signaling

G House - Authorea Preprints, 2023 - essopenarchive.org
Cancers of the blood stemming from genetic or environmental abnormalities are included in
the broad category of blood diseases. Some forms of leukemia may respond better to …

miRNA: A Potential Breast Cancer Treatment? How did we get here?

C Bush - Authorea Preprints, 2023 - essopenarchive.org
Objective The purpose of this research was to summarize what is currently known about the
role of microRNAs in breast cancer and their possible clinical use based on articles …